La información más actual para el médico de familia
Prensa Tema Resúmenes Revistas Internet Usuarios registrados | Quiénes somos
Más actualidad
Buscador
 
Búsqueda avanzada

Revistas

(Semana 13/05/2013 - 19/05/2013)

BMJ-British Medical Journal. Vol. 346. Núm. 7908

Originales

Bell KJ, Fulcher ML, Rowlands DS, Kerse N Impact of autologous blood injections in treatment of mid-portion Achilles tendinopathy: double blind randomised controlled trial. Págs. f2310 TC PDF 

Toren P, Margel D, Kulkarni G, Finelli A, Zlotta A, Fleshner N Effect of dutasteride on clinical progression of benign prostatic hyperplasia in asymptomatic men with enlarged prostate: a post hoc analysis of the REDUCE study. Págs. f2109 TC PDF 

Eurich DT, Simpson S, Senthilselvan A, Asche CV, Sandhu-Minhas JK, McAlister FA Comparative safety and effectiveness of sitagliptin in patients with type 2 diabetes: retrospective population based cohort study. Págs. f2267 TC PDF 

Editoriales

Richards T, Montori VM, Godlee F, Lapsley P, Paul D Let the patient revolution begin. Págs. f2614 TC (s) PDF (s) 

Segal J Should we be reassured about sitagliptin?. Págs. f3051 TC (s) PDF (s) 

Maffulli N Autologous blood products in musculoskeletal medicine. Págs. f2979 TC (s) PDF (s) 

Sugarman J Implications of universal screening for HIV infection. Págs. f2957 TC (s) PDF (s) 

Revisiones

Boland B, Burnage J, Chowhan H Safeguarding adults at risk of harm. Págs. f2716 TC (s) PDF (s) 

Práctica clínica

Edmiston R, Mitchell C 10-Minute Consultation: Hearing loss in adults. Págs. f2496 TC (s) PDF (s) 

New England Journal of Medicine. Vol. 368. Núm. 20

Originales

Jacobson IM, Gordon SC, Kowdley KV, Yoshida EM, Rodriguez-Torres M, Sulkowski MS et alSofosbuvir for Hepatitis C Genotype 2 or 3 in Patients without Treatment Options. Págs. 1867-1877 TC (s) PDF (s) 

Lawitz E, Mangia A, Wyles D, Rodriguez-Torres M, Hassanein T, Gordon SC et alSofosbuvir for Previously Untreated Chronic Hepatitis C Infection. Págs. 1878-1887 TC (s) PDF (s) 

Gao R, Cao B, Hu Y, Feng Z, Wang D, Hu W et alHuman Infection with a Novel Avian-Origin Influenza A (H7N9) Virus. Págs. 1888-1897 TC (s) PDF (s) 

Editoriales

Drenth JPHCV Treatment — No More Room for Interferonologists?. Págs. 1931-1932 TC (s) PDF (s) 

Blumenthal D, Abrams MKPutting Aside Preconceptions — Time for Dialogue among Primary Care Clinicians. Págs. 1933-1934 TC (s) PDF (s) 

Revisiones

Liang TJ, Ghany MGDrug Therapy: Current and Future Therapies for Hepatitis C Virus Infection. Págs. 1907-1917 TC (s) PDF (s) 

Perspectiva

Frieden TRGovernment's Role in Protecting Health and Safety. Págs. 1857-1859 TC PDF 

Holmberg SD, Spradling PR, Moorman AC, Denniiston MMHepatitis C in the United States. Págs. 1859-1861 TC (s) PDF (s) 

Uyeki TM, Cox NJGlobal Concerns Regarding Novel Influenza A (H7N9) Virus Infections. Págs. 1862-1864 TC PDF 

Artículo especial

Donelan K, DesRoches CM, Dittus RS, Buerhaus PPerspectives of Physicians and Nurse Practitioners on Primary Care Practice. Págs. 1898-1906 TC (s) PDF (s) 

Iglehart JKExpanding the Role of Advanced Nurse Practitioners — Risks and Rewards. Págs. 1935-1941 TC PDF 

The Lancet. Vol. 381. Núm. 98783

Originales

Alkema L, Kantorova V, Menozzi C, Biddlecom ANational, regional, and global rates and trends in contraceptive prevalence and unmet need for family planning between 1990 and 2015: a systematic and comprehensive analysis. Págs. 1642-1652 R TC PDF 

Editoriales

 Bipolar disorder: at the extremes. Págs. 1597 TC PDF 

Comentario

Malhi GSDiagnosis of bipolar disorder: who is in a mixed state?. Págs. 1599-1600 TC PDF 

Kehlet H Fast-track hip and knee arthroplasty. Págs. 1600-1602 TC PDF 

Series

Craddock N, Sklar PGenetics of bipolar disorder. Págs. 1654-1662 R TC PDF 

Phillips ML, Kupfer DJBipolar disorder diagnosis: challenges and future directions. Págs. 1663-1671 R TC PDF 

Geddes JR, Miklowitz DJTreatment of bipolar disorder. Págs. 1672-1682 R TC PDF 

JAMA. The Journal of the American Medical Association. Vol. 309. Núm. 19

Originales

The Age-Related Eye Disease Study 2 (AREDS2) Research Group Lutein + Zeaxanthin and Omega-3 Fatty Acids for Age-Related Macular Degeneration: The Age-Related Eye Disease Study 2 (AREDS2) Randomized Clinical Trial. Págs. 2005-2015 TC (s) 

Nygaard I, Brubaker L, Zyczynski HM, Cundiff G, Richter H, Gantz M et al Long-term Outcomes Following Abdominal Sacrocolpopexy for Pelvic Organ Prolapse. Págs. 2016-2024 TC (s) 

Editoriales

Iglesia CB Pelvic Organ Prolapse Surgery: Long-term Outcomes and Implications for Shared Decision Making. Págs. 2045-2046 TC (s) 

Páginas para los pacientes

Alford DP, Livingston EH Misuse of Opioid Medication. Págs. 2055 TC PDF 

Punto de vista

CI DR, Kiley JW, Hammond C Contraception Is a Fundamental Primary Care Service . Págs. 1997-1998 TC (s) 

Exploración clínica racional

Hollands H, Johnson D, Hollands S, Simel DL, Jinapriya D, Sharma S Do Findings on Routine Examination Identify Patients at Risk for Primary Open-Angle Glaucoma?: The Rational Clinical Examination Systematic Review. Págs. 2035-2042 TC (s) 

JAMA Internal Medicine. Vol. 137. Núm. 9

Originales

Johannesdottir SA, Horváth-Puhó E, Dekkers O, Cannegieter SC, Jørgensen JO, Ehrenstein V et al Use of Glucocorticoids and Risk of Venous Thromboembolism: A Nationwide Population-Based Case-Control Study. Págs. 743-752 TC (s) 

Berry SD, Lee Y, Cai S, Dore DD Nonbenzodiazepine Sleep Medication Use and Hip Fractures in Nursing Home Residents. Págs. 754-761 TC (s) 

Kerlikowske K, Zhu W, Hubbard RA, Geller B, Dittus K, Braithwaite D et al Outcomes of Screening Mammography by Frequency, Breast Density, and Postmenopausal Hormone Therapy. Págs. 807-816 TC (s) 

Comentario

Widera E What's to Blame for Falls and Fractures? Poor Sleep or the Sleeping Medication?: Comment on “Nonbenzodiazepine Sleep Medication Use and Hip Fractures in Nursing Home Residents” PDF PDF. Págs. 761-762 TC (s) 

Lautenschlager NT, Cox KL Can Participation in Mental and Physical Activity Protect Cognition in Old Age? : Comment on “The Mental Activity and eXercise (MAX) Trial: A Randomized Controlled Trial to Enhance Cognitive Function in Older Adults” . Págs. 805-806 TC (s) 

Barnes DE, Santos-Modesitt W, Poelke G, Kramer AF, Castro C, Middleton LE, Yaffe K The Mental Activity and eXercise (MAX) Trial: A Randomized Controlled Trial to Enhance Cognitive Function in Older Adults. Págs. 797-804 TC (s) 

Annals of Internal Medicine. Vol. 158. Núm. 9

Originales

Raghu G, Behr J, Brown KK, Egan JJ, Kawut SM, Flaherty KR et al and the ARTEMIS-IPF Investigators Treatment of Idiopathic Pulmonary Fibrosis With Ambrisentan: A Parallel, Randomized Trial. Págs. 641-649 TC (s) 

Kirk GD, Mehta SH, Astemborski J, Galai N, Washington J, Higgins Y et al HIV, Age, and the Severity of Hepatitis C Virus–Related Liver Disease: A Cohort Study. Págs. 658-666 TC (s) 

Editoriales

Nestle M, Nesheim MC To Supplement or Not to Supplement: The U.S. Preventive Services Task Force Recommendations on Calcium and Vitamin D. Págs. 701-702 TC PDF 

Revisiones

Raman G, Moorthy D, Hadar N, Dahabreh IJ, O'Donnell TF, Thaler DE et al Management Strategies for Asymptomatic Carotid Stenosis: A Systematic Review and Meta-analysis. Págs. 676-685 TC (s) PDF 

Guías de práctica clínica

Moyer VA on behalf of the U.S. Preventive Services Task Force Vitamin D and Calcium Supplementation to Prevent Fractures in Adults: U.S. Preventive Services Task Force Recommendation Statement. Págs. 691-696 TC PDF 

En la consulta

Mandel J, Poch ,D Pulmonary Hypertension. Págs. ITC5 TC (s) 

Medicina Clínica. Vol. 140. Núm. 10

Originales

Gómez-Vaquero C, Roig-Vilaseca D, Bianchi M, Santo P, Narváez J, Nolla JM Evaluación de una propuesta de criterios de indicación de densitometría ósea en mujeres posmenopáusicas españolas basados en la herramienta FRAX ® . Págs. 439-443 R TC (s) 

Revisiones

Ruiz F, Castellano MM, Aparisi F Papel de la radiología intervencionista en el diagnóstico y tratamiento de la columna vertebral dolorosa . Págs. 458-465 R TC (s) 

Circulation. Vol. 127. Núm. 19

Originales

Allan GM, Nouri F, Korownyk C, Kolber MR, Vandermeer B, McCormack JAgreement Among Cardiovascular Disease Risk Calculators. Págs. 1948-1956 R TC (s) PDF (s) 

Editoriales

Jackson R, Kerr A, Wells SVascular Risk Calculators: Essential but Flawed Clinical Tools?. Págs. 1929-1931 TC (s) PDF (s) 

Revisiones

Rutherford JDDigital Clubbing. Págs. 1997-1999 TC PDF 

Gaceta Sanitaria. Vol. 27. Núm. 3

Originales

Ortún V Las encrucijadas de la atención primaria . Págs. 193-195 TC PDF 

Aller M, Vargas I, Waibel S, Coderch-Lassaletta J, Sánchez-Pérez I, Llopart JR et alFactores asociados a la continuidad asistencial entre atención primaria y atención secundaria ambulatoria experimentada por los usuarios en el sistema de salud catalán . Págs. 207-213 R TC PDF 

European Heart Journal. Vol. 34. Núm. 18

Originales

Sondermeijer BM, Boekholdt SM, Rana JS, Kastelein JJ, Wareham NJ, Khaw KClinical implications of JUPITER in a contemporary European population: the EPIC-Norfolk prospective population study . Págs. 1350-1357 R TC PDF 

Zittermann A, Kuhn J, Dreier J, Knabbe C, Gummert JF, Börgermann JVitamin D status and the risk of major adverse cardiac and cerebrovascular events in cardiac surgery. Págs. 1358-1364 R TC (s) PDF (s) 

Tomson J, Emberson J, Hill M, Gordon A, Armitage J, Shipley M et alVitamin D and risk of death from vascular and non-vascular causes in the Whitehall study and meta-analyses of 12 000 deaths . Págs. 1365-1374 R TC PDF 

Editoriales

Chapman MJ, Giral P, Barter PJThe conundrum of C-reactive protein as a risk marker for cardiovascular risk assessment: insight from EPIC-Norfolk and JUPITER. Págs. 1318-1320 TC (s) PDF (s) 

Claves

R Resumen    TC Texto completo    PDF Portable Document File (Adobe Reader)    RC Resumen comentado    (s) Sólo suscriptores   

Contacto con AP al día: apaldia@apaldia.com
© MEDIGRAF 2013.
Esta web se dirige exclusivamente a los profesionales del sector médico.